Regulatory T cells and dendritic cells in transplantation tolerance: Molecular markers and mechanisms

Immunological Reviews

Volumn 196, Issue , 2003, Pages 109-124

  Cobbold, Stephen P ^a   Nolan, Kathleen F ^a   Graca, Luis ^a   Castejon, Raquel ^b   Le Moine, Alain ^c   Frewin, Mark ^a   Humm, Susan ^a   Adams, Elizabeth ^a   Thompson, Sara ^d   Zelenika, Diana ^e   Paterson, Alison ^a   Yates, Stephen ^a   Fairchild, Paul J ^a   Waldmann, Herman ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^c ERASME HOSPITAL   (Belgium)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e CENTRE NATIONAL DE GÉNOTYPAGE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; COLECALCIFEROL; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR; MOLECULAR MARKER; MONOCLONAL ANTIBODY;

ANALYTIC METHOD; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; CELL CLONE; CELL INTERACTION; CELL MATURATION; CELL SURFACE; CELL TYPE; DENDRITIC CELL; DRUG EFFECT; EMBRYO CELL; GENE EXPRESSION; GENE FUNCTION; GENE LIBRARY; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; GRAFT REJECTION; HUMAN; IMMUNE SYSTEM; IMMUNOREGULATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE SUBPOPULATION; MOLECULAR MECHANICS; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; REGULATORY MECHANISM; RELIABILITY; REVIEW; SEQUENCE ANALYSIS; SPLEEN; STEM CELL; T LYMPHOCYTE; TRANSPLANTATION TOLERANCE;

ANIMALS; ANTIGENS, CD; DENDRITIC CELLS; GENE EXPRESSION PROFILING; HUMANS; T-LYMPHOCYTES; TRANSPLANTATION TOLERANCE;

EID: 10744226541     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1600-065X.2003.00078.x     Document Type: Review

References (84)

1. Hall BM, Jelbart ME, Gurley KE, Dorsch SE. Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. Mediation of specific suppression by T helper/inducer cells. J Exp Med 1985;162:1683-1694.
2. Qin S, et al. "Infectious" transplantation tolerance. Science 1993;259:974-977.
3. Powrie F, Leach MW, Mauze S, Caddle LB, Coffman RL. Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice. Int Immunol 1993;5:1461-1471.
4. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995;155:1151-1164.
5. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997;389:737-742.
6. Waldmann H, Cobbold S. Regulating the immune response to transplants. A role for CD4+ regulatory cells? Immunity 2001;14:399-406.
7. Jonuleit H, Schmitt E, Schuler G, Knop J, Enk AH. Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med 2000;192:1213-1222.
8. Jonuleit H, Schmitt E, Steinbrink K, Enk AH. Dendritic cells as a tool to induce anergic and regulatory T cells. Trends Immunol 2001;22:394-400.
9. Roncarolo MG, Levings MK, Traversari C. Differentiation of T regulatory cells by immature dendritic cells. J Exp Med 2001;193:F5-F9.
10. Steinbrink K, Graulich E, Kubsch S, Knop J, Enk AH. CD4(+) and CD8(+) anergic T cells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity. Blood 2002;99: 2468-2476.
11. Gregori S, Casorati M, Amuchastegui S, Smiroldo S, Davalli AM, Adorini L. Regulatory T cells induced by 1 alpha, 25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J Immunol 2001;167:1945-1953.
12. Fairchild PJ, Waldmann H. Dendritic cells and prospects for transplantation tolerance. Curr Opin Immunol 2000;12:528-535.
13. Scully R, Qin S, Cobbold S, Waldmann H. Mechanisms in CD4 antibody-mediated transplantation tolerance: kinetics of induction, antigen dependency and role of regulatory T cells. Eur J Immunol 1994;24:2383-2392.
14. Saitovitch D, Bushell A, Mabbs DW, Morris PJ, Wood KJ. Kinetics of induction of transplantation tolerance with a nondepleting anti-Cd4 monoclonal antibody and donor-specific transfusion before transplantation. A critical period of time is required for development of immunological unresponsiveness. Transplantation 1996;61:1642-1647.
15. Cobbold SP, Adams E, Marshall SE, Davies JD, Waldmann H. Mechanisms of peripheral tolerance and suppression induced by monoclonal antibodies to CD4 and CD8. Immunol Rev 1996;149:5-33.
16. Chen ZK, Cobbold SP, Waldmann H, Metcalfe S. Amplification of natural regulatory immune mechanisms for transplantation tolerance. Transplantation 1996;62:1200-1206.
17. Davies JD, Leong LY, Mellor A, Cobbold SP, Waldmann H. T cell suppression in transplantation tolerance through linked recognition. J Immunol 1996;156: 3602-3607.
18. Wong W, Morris PJ, Wood KJ. Pretransplant administration of a single donor class I major histocompatibility complex molecule is sufficient for the indefinite survival of fully allogeneic cardiac allografts: evidence for linked epitope suppression. Transplantation 1997;63:1490-1494.
19. Bemelman F, Honey K, Adams E, Cobbold S, Waldmann H. Bone marrow transplantation induces either clonal deletion or infectious tolerance depending on the dose. J Immunol 1998;160:2645-2648.
20. Honey K, Cobbold SP, Waldmann H. CD40 ligand blockade induces CD4+ T cell tolerance and linked suppression. J Immunol 1999;163:4805-4810.
21. Cobbold S, Waldmann H. Infectious tolerance. Curr Opin Immunol 1998;10:518-524.
22. Onodera K, Lehmann M, Akalin E, Volk HD, Sayegh MH, Kupiec-Weglinski JW. Induction of "infectious" tolerance to MHC-incompatible cardiac allografts in CD4 monoclonal antibody-treated sensitized rat recipients. J Immunol 1996;157:1944-1950.
23. Wise MP, Bemelman F, Cobbold SP, Waldmann H. Linked suppression of skin graft rejection can operate through indirect recognition. J Immunol 1998;161:5813-5816.
24. Graca L, Cobbold SP, Waldmann H. Identification of regulatory T cells in tolerated allografts. J Exp Med 2002;195:1641-1646.
25. Zhai Y, Kupiec-Weglinski JW. What is the role of regulatory T cells in transplantation tolerance? Curr Opin Immunol 1999;11:497-503.
26. - and IL-10-dependent immunoregulation of alloresponses. J Immunol 2002;168:1080-1086.
27. Graca L, Thompson S, Lin CY, Adams E, Cobbold SP, Waldmann H. Both CD4(+) CD25(+) and CD4(+) CD25(-) regulatory cells mediate dominant transplantation tolerance. J Immunol 2002;168:5558-5565.
28. Wood KJ, Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat Rev Immunol 2003;3:199-210.
29. Barthlott T, Kassiotis G, Stockinger B. T Cell regulation as a side effect of homeostasis and competition. J Exp Med 2003;197:451-460.
30. Marshall SE, Cobbold SP, Davies JD, Martin GM, Phillips JM, Waldmann H. Tolerance and suppression in a primed immune system. Transplantation 1996;62:1614-1621.
31. + T cells or B cells. J Immunol 1998;161:1868-1874.
32. Lin CY, Graca L, Cobbold SP, Waldmann H. Dominant transplantation tolerance impairs CD8+ T cell function but not expansion. Nat Immunol 2002;3:1208-1213.
33. Curtsinger JM, Lins DC, Mescher MF. Signal 3 determines tolerance versus full activation of naïve CD8 T cells: dissociating proliferation and development of effector function. J Exp Med 2003;197:1141-1151.
34. Takahashi T, et al. Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med 2000;192:303-310.
35. + T cell alloantigen-specific hyporesponsiveness by IL-10 and TGF-beta. J Immunol 1999;163:3684-3691.
36. Waldmann H. Reprogramming the immune system. Immunol Rev 2002;185:227-235.
37. Gallucci S, Matzinger P. Danger signals: SOS to the immune system. Curr Opin Immunol 2001;13:114-119.
38. Qin SX, Cobbold S, Benjamin R, Waldmann H. Induction of classical transplantation tolerance in the adult. J Exp Med 1989;169:779-794.
39. Qin SX, et al. Induction of tolerance in peripheral T cells with monoclonal antibodies. Eur J Immunol 1990;20: 2737-2745.
40. Waldmann H, Qin S, Cobbold S. Monoclonal antibodies as agents to reinduce tolerance in autoimmunity. J Autoimmun 1992;5:93-102.
41. Waldmann H, Cobbold S. How do monoclonal antibodies induce tolerance? A role for infectious tolerance? Annu Rev Immunol 1998;16:619-644.
42. Velculescu VE, Zhang L, Vogelstein B, Kinder KW. Serial analysis of gene expression. Science 1995;270:484-487.
43. Zelenika D, et al. Regulatory T cells overexpress a subset of Th2 gene transcripts. J Immunol 2002;168:1069-1079.
44. Zelenika D, Adams E, Humm S, Lin CY, Waldmann H, Cobbold SP. The role of CD4+ T-cell subsets in determining transplantation rejection or tolerance. Immunol Rev 2001;182:164-179.
45. Adorini L, Penna G, Giarratana N, Uskokovic M. Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting allograft rejection and autoimmune diseases. J Cell Biochem 2003;88:227-233.
46. Madden SL, Galella EA, Zhu J, Bertelsen AH, Beaudry GA. SAGE transcript profiles for p53-dependent growth regulation. Oncogene 1997;15:1079-1085.
47. Hashimoto SI, et al. Gene expression profile in human leukocytes. Blood 2003;101: 3509-3513.
48. Chen J, Sun M, Lee S, Zhou G, Rowley JD, Wang SM. Identifying novel transcripts and novel genes in the human genome by using novel SAGE tags. Proc Natl Acad Sci USA 2002;99:12257-12262.
49. Velculescu VE, et al. Characterization of the yeast transcriptome. Cell 1997;88:243-251.
50. Caron H, et al. The human transcriptome map: clustering of highly expressed genes in chromosomal domains. Science 2001;291:1289-1292.
51. Lash AE, et al. SAGEmap: a public gene expression resource. Genome Res 2000;10:1051-1060.
52. Saha S, et al. Using the transcriptome to annotate the genome. Nat Biotechnol 2002;20:508-512.
53. Anisimov SV, Tarasov KV, Tweedie D, Stern MD, Wobus AM, Boheler KR. SAGE identification of gene transcripts with profiles unique to pluripotent mouse R1 embryonic stem cells. Genomics 2002;79:169-176.
54. + intraepithelial lymphocytes provided by serial analysis of gene expression (SAGE). Immunity 2001;15:419-434.
55. Shimazaki T, Okazawa H, Fujii H, Ikeda M, Tamai K, McKay RD, et al. Hybrid cell extinction and re-expression of Oct-3 function correlates with differentiation potential. EMBO J 1993;12:4489-4498.
56. Shimizu J, Yamazaki S, Takahashi T, Ishida Y, Sakaguchi S. Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance. Nat Immunol 2002;3:135-142.
57. + cytolytic T cells and responsiveness to IL-2 but not cytolytic activity. J Immunol 2002;169:4230-4236.
58. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 1998;188:287-296.
59. Schaffer A, Cerutti A, Shah S, Zan H, Casali P. The evolutionarily conserved sequence upstream of the human Ig heavy chain S gamma 3 region is an inducible promoter: synergistic activation by CD40 ligand and IL-4 via cooperative NF-kappa B and STAT-6 binding sites. J Immunol 1999;162:5327-5336.
60. Singh B, et al. Control of intestinal inflammation by regulatory T cells. Immunol Rev 2001;182:190-200.
61. + regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev 2001;182:18-32.
62. McHugh RS, et al. CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 2002;16:311-323.
63. Read S, Malmstrom V, Powrie F. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J Exp Med 2000;192:295-302.
64. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor foxp3. Science 2003;299:1057-1061.
65. - regulatory T cells. Proc Natl Acad Sci USA 2002;99: 13031-13036.
66. Zheng W, Flavell RA. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 1997;89:587-596.
67. Nawijn MC, et al. Enforced expression of GATA-3 in transgenic mice inhibits Th1 differentiation and induces the formation of a T1/ST2-expressing Th2-committed T cell compartment in vivo. J Immunol 2001;167:724-732.
68. Miaw SC, Choi A, Yu E, Kishikawa H, Ho IC. ROG, repressor of GATA, regulates the expression of cytokine genes. Immunity 2000;12:323-333.
69. Moratz C, et al. Regulator of G protein signaling 1 (RGS1) markedly impairs Gi alpha signaling responses of B lymphocytes. J Immunol 2000;164:1829-1838.
70. Reif K, Cyster JG. RGS molecule expression in murine B lymphocytes and ability to down-regulate chemotaxis to lymphoid chemokines. J Immunol 2000;164:4720-4729.
71. Monteyne P, Renauld JC, Van Broeck J, Dunne DW, Brombacher F, Coutelier JP. IL-4-independent regulation of in vivo IL-9 expression. J Immunol 1997;159:2616-2623.
72. Brown JA, et al. Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production. J Immunol 2003;170:1257-1266.
73. Langrish CL, Buddle JC, Thrasher AJ, Goldblatt D. Neonatal dendritic cells are intrinsically biased against Th-1 immune responses. Clin Exp Immunol 2002;128:118-123.
74. Goerdt S, Orfanos CE. Other functions, other genes: alternative activation of antigen-presenting cells. Immunity 1999;10:137-142.
75. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001;19:683-765.
76. Ehlert JE, Ludwig A, Grimm TA, Lindner B, Flad HD, Brandt E. Down-regulation of neutrophil functions by the ELR(+) CXC chemokine platelet basic protein. Blood 2000;96:2965-2972.
77. Soares MP, Brouard S, Smith RN, Bach FH. Heme oxygenase-1, a protective gene that prevents the rejection of transplanted organs. Immunol Rev 2001;184:275-285.
78. + T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms. J Exp Med 2003;197:111-119.
79. Chen H, Centola M, Altschul SF, Metzger H. Characterization of gene expression in resting and activated mast cells. J Exp Med 1998;188:1657-1668.
80. Powell J. Enhanced concatemer cloning-a modification to the SAGE (Serial Analysis of Gene Expression) technique. Nucleic Acids Res 1998;26:3445-3446.
81. Barrat FJ, et al. In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)-and Th2-inducing cytokines. J Exp Med 2002;195:603-616.
82. Inaba K, et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/ macrophage colony-stimulating factor. J Exp Med 1992;176:1693-1702.
83. Fairchild PJ, et al. Directed differentiation of dendritic cells from mouse embryonic stem cells. Curr Biol 2000;10:1515-1518.
84. Fairchild PJ, Nolan KP, Waldmann H. Probing dendritic cell function by guiding the differentiation of embryonic stem cells. Methods Enzymol 2003;365:169-186.